Literature DB >> 15967097

Differential expression of IGF components and insulin receptor isoforms in human seminoma versus normal testicular tissue.

Tanja Pascale Neuvians1, Isabella Gashaw, Andrea Hasenfus, Axel Hacherhäcker, Elke Winterhager, Rainer Grobholz.   

Abstract

Insulin-like growth factors (IGF) have mitogenic and antiapoptotic functions, and may be involved in tumor growth. The purpose of the study was to investigate the role of IGF components in seminoma compared to normal testis. Normal testicular tissues from autopsy cases and seminoma from surgery cases were obtained for microarray and real-time reverse transcription polymerase chain reaction (RT-PCR) analysis of IGF-1, IGF-2, IGF receptor type 1 (IGF-R1), IGF-R2, insulin receptor isoforms A (IR-A) and B (IR-B), and IGF-binding proteins (IGFBP) 1-6. IGF-2 was localized by immunohistochemistry. IGFBP-5 protein expression was evaluated by Western blot analysis. mRNA expression in microarray and real-time RT-PCR showed similar tendencies: IGF-1, IGF-R1, IGF-R2, IR-A, and IGFBP-2 were not different in both groups. IGF-2, IR-B, IGFBP-1, IGFBP-4, and IGFBP-6 mRNA were downregulated in seminoma. IGFBP-3 tended to be upregulated in pT1 seminoma, but downregulated in pT2 stages. IGFBP-5 and IGF-2 protein expression correlated with mRNA expression. In conclusion, downregulation of mainly inhibiting IGFBPs may allow a stimulated tumor growth. The downregulated IGF-2 does not seem to be involved in the growth regulation of seminoma. Constantly expressed genes (e.g., IGF-1, IGF-R1, IR-A, and IGFBP-2) may reflect an involvement in spermatogenesis, but may also play a major role in tumor growth as their expression is not downregulated despite the lack of spermatogenesis in tumor tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967097      PMCID: PMC1501162          DOI: 10.1593/neo.04643

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  38 in total

1.  NetAffx: Affymetrix probesets and annotations.

Authors:  Guoying Liu; Ann E Loraine; Ron Shigeta; Melissa Cline; Jill Cheng; Venu Valmeekam; Shaw Sun; David Kulp; Michael A Siani-Rose
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

2.  Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation.

Authors:  S E Damon; L Maddison; J L Ware; S R Plymate
Journal:  Endocrinology       Date:  1998-08       Impact factor: 4.736

3.  Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium.

Authors:  Elin Richardsen; Tanja Ukkonen; Tone Bjørnsen; Elin Mortensen; Lars Egevad; Christer Busch
Journal:  Virchows Arch       Date:  2003-04-01       Impact factor: 4.064

4.  Insulin-like growth factor-I (IGF-I) and IGF-I receptor in human testis: an immunohistochemical study.

Authors:  B G Vannelli; T Barni; C Orlando; A Natali; M Serio; G C Balboni
Journal:  Fertil Steril       Date:  1988-04       Impact factor: 7.329

5.  A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer.

Authors:  Veronica Vella; Giuseppe Pandini; Laura Sciacca; Rossana Mineo; Riccardo Vigneri; Vincenzo Pezzino; Antonino Belfiore
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

6.  Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells.

Authors:  Emma Marshman; Kirsty A Green; David J Flint; Anne White; Charles H Streuli; Melissa Westwood
Journal:  J Cell Sci       Date:  2003-02-15       Impact factor: 5.285

7.  Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.

Authors:  J G Reeve; J Morgan; J Schwander; N M Bleehen
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

8.  Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo.

Authors:  Alison J Butt; Kristie A Dickson; Fiona McDougall; Robert C Baxter
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

Review 9.  The insulin-like growth factor system and cancer.

Authors:  Derek LeRoith; Charles T Roberts
Journal:  Cancer Lett       Date:  2003-06-10       Impact factor: 8.679

10.  Immunohistochemical localization of androgen receptors in the rat testis: evidence for stage-dependent expression and regulation by androgens.

Authors:  W J Bremner; M R Millar; R M Sharpe; P T Saunders
Journal:  Endocrinology       Date:  1994-09       Impact factor: 4.736

View more
  5 in total

Review 1.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

2.  Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure.

Authors:  Shaan Chugh; Maral Ouzounian; Zhen Lu; Shanas Mohamed; Wenping Li; Nicolas Bousette; Peter P Liu; Anthony O Gramolini
Journal:  Proteomics       Date:  2013-07-01       Impact factor: 3.984

3.  Claudin-11 is over-expressed and dislocated from the blood-testis barrier in Sertoli cells associated with testicular intraepithelial neoplasia in men.

Authors:  Cornelia Fink; Roswitha Weigel; Ludger Fink; Jochen Wilhelm; Sabine Kliesch; Martina Zeiler; Martin Bergmann; Ralph Brehm
Journal:  Histochem Cell Biol       Date:  2009-02-25       Impact factor: 4.304

4.  Expression of the Insulin-like Growth Factor System in First- and Second-Trimester Human Embryonic and Fetal Gonads.

Authors:  Linn Salto Mamsen; Aikaterini Zafeiri; Jane Alrø Bøtkjær; Jonna Rasmussen Hardlei; Erik Ernst; Claus Oxvig; Paul A Fowler; Claus Yding Andersen
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

Review 5.  Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment.

Authors:  Kunal Amratlal Lodhia; Piyawan Tienchaiananda; Paul Haluska
Journal:  Front Oncol       Date:  2015-07-08       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.